Neumora Therapeutics Inc (NMRA)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Show more
Ask ADVFN Intelligence (AI)
WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven...
Phase 3 data from KOASTAL-1 study of navacaprant in MDD expected in fourth quarter of 2024 Progressing clinical studies in MDD, bipolar depression and Alzheimer’s disease agitation, providing...
NMRA-511 is a highly potent and selective, best-in-class, antagonist of the vasopressin 1a receptor, which is known to play a role in regulation of aggression, stress and anxiety response...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 0.175746924429 | 11.38 | 12.2999 | 10.35 | 375794 | 11.37876608 | CS |
| 4 | 2.4 | 26.6666666667 | 9 | 13.4105 | 8.33 | 817446 | 10.72324572 | CS |
| 12 | -6.55 | -36.4902506964 | 17.95 | 18.61 | 8.33 | 726305 | 11.2474065 | CS |
| 26 | -5.1 | -30.9090909091 | 16.5 | 21 | 8.33 | 525597 | 12.03118721 | CS |
| 52 | -5.1 | -30.9090909091 | 16.5 | 21 | 8.33 | 525597 | 12.03118721 | CS |
| 156 | -5.1 | -30.9090909091 | 16.5 | 21 | 8.33 | 525597 | 12.03118721 | CS |
| 260 | 0 | 0 | 0 | 11.8 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
